Updated just now · Live
Stock analysis, price data, and AI-powered insights for ANI Pharmaceuticals Inc (ANIP).
ANI Pharmaceuticals Inc operates in the Pharmaceuticals sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ANIP.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ANIP Stock Intelligence Report. [stoxpulse.com/stocks/anip]
Disclaimer: The information on this page about ANI Pharmaceuticals Inc (ANIP) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for ANI Pharmaceuticals Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
ANI Pharmaceuticals, Inc. Announces FDA Approval A...
1d ago
ANI Pharmaceuticals Announces Launch Of Pimozide T...
1d ago
StoxPulse AI results for ANIP: Pulse Score 60/100. Primary sentiment trends from 3 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$1.83B
P/E Ratio
—
EPS
$1.13
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
ANI Pharmaceuticals, Inc. Announces FDA Approval And Launch Of Pimozide Tablets
ANI Pharmaceuticals Announces Launch Of Pimozide Tablets 1 Mg And 2 Mg, Generic Version Of Reference Listed Drug Orap, With 180-Day CGT Exclusivity
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity